Innate Pharma S.A. Sponsored ADR (IPHA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
View Innate Pharma SA Sponsored ADR IPHA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Fintel reports that on October 29, 2025, BTIG reiterated coverage of Innate Pharma S.A. - Depositary Receipt (NasdaqGS:IPHA) with a Buy recommendation. As of September 30, 2025, the average one-year ...
Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today. At this time, I would like to welcome everyone to the Innate Pharma First Quarter 2025 Financial ...
Hosted on MSN
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers
The company said that the planned confirmation late-stage trial is designed to demonstrate the efficacy of Lacutamab in certain patients with Sézary syndrome and Mycosis fungoides. The primary goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results